Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1984 Aug;43(4):556–562. doi: 10.1136/ard.43.4.556

Eosinophil cationic protein in inflammatory synovial effusions as evidence of eosinophil involvement.

R Hällgren, A Bjelle, P Venge
PMCID: PMC1001407  PMID: 6236759

Abstract

Eosinophils are seldom noted in inflammatory synovial fluids but are reported to infiltrate the synovial tissue in inflammatory arthritides. To elucidate a possible role for eosinophils in inflammatory joint reactions the concentrations of eosinophil cationic protein (ECP)--a specific granule protein from eosinophils--were measured by radioimmunoassay in 90 synovial fluids from patients with various inflammatory arthritides (rheumatoid arthritis, reactive and crystal arthritides, Reiter's disease and psoriatic arthropathy). In the same specimens lactoferrin was measured as an indicator of neutrophil-involved inflammation. In comparison with the normal circulating levels of ECP and lactoferrin the measured synovial fluid concentrations of both proteins were considerably raised in all patient groups with inflammatory joint diseases in contrast to patients with non-inflammatory arthritides. There was a striking positive correlation between the ECP and lactoferrin synovial fluid concentrations. These data indicate that eosinophil activation is prominent in inflammatory joint reactions and is linked to the activation of neutrophils. The regulation of degranulation or secretion by eosinophils is unknown. Our in-vitro studies showed that peripheral blood isolated neutrophils as well as eosinophils degranulated when exposed to IgG complexes. However, eosinophil degranulation was modest compared with neutrophil degranulation. These data suggest that neutrophil phagocytosis of, for example, immune complexes may be one major mechanism in neutrophil degranulation but that other factors determine the appearance of eosinophil products in inflammatory synovial effusions. The possible modulatory or harmful role of eosinophils in inflammatory joint disease can at present only be speculated on.

Full text

PDF
556

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Butterworth A. E., Sturrock R. F., Houba V., Rees P. H. Antibody-dependent cell-mediated damage to schistosomula in vitro. Nature. 1974 Dec 6;252(5483):503–505. doi: 10.1038/252503a0. [DOI] [PubMed] [Google Scholar]
  2. Cline M. J., Hanifin J., Lehrer R. I. Phagocytosis by human eosinophils. Blood. 1968 Dec;32(6):922–934. [PubMed] [Google Scholar]
  3. Frigas E., Loegering D. A., Solley G. O., Farrow G. M., Gleich G. J. Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma. Mayo Clin Proc. 1981 Jun;56(6):345–353. [PubMed] [Google Scholar]
  4. GLASER R. J., WOOD W. B., Jr Pathogenesis of streptococcal pneumonia in the rat. AMA Arch Pathol. 1951 Sep;52(3):244–252. [PubMed] [Google Scholar]
  5. Hubscher T. Role of the eosinophil in the allergic reactions. II. Release of prostaglandins from human eosinophilic leukocytes. J Immunol. 1975 Apr;114(4):1389–1393. [PubMed] [Google Scholar]
  6. Ishikawa T., Wicher K., Arbesman C. E. In vitro and in vivo studies on uptake of antigen-antibody complexes by eosinophils. Int Arch Allergy Appl Immunol. 1974;46(2):230–248. doi: 10.1159/000231126. [DOI] [PubMed] [Google Scholar]
  7. Ludlam C. A., Moore S., Bolton A. E., Pepper D. S., Cash J. D. The release of a human platelet specific protein measured by a radioimmunoassay. Thromb Res. 1975 Jun;6(6):543–548. doi: 10.1016/0049-3848(75)90066-3. [DOI] [PubMed] [Google Scholar]
  8. MARCHESI V. T., FLOREY H. W. Electron micrographic observations on the emigration of leucocytes. Q J Exp Physiol Cogn Med Sci. 1960 Oct;45:343–348. doi: 10.1113/expphysiol.1960.sp001489. [DOI] [PubMed] [Google Scholar]
  9. McLaren D. J., McKean J. R., Olsson I., Venges P., Kay A. B. Morphological studies on the killing of schistosomula of Schistosoma mansoni by human eosinophil and neutrophil cationic proteins in vitro. Parasite Immunol. 1981 Winter;3(4):359–373. doi: 10.1111/j.1365-3024.1981.tb00414.x. [DOI] [PubMed] [Google Scholar]
  10. Mickenberg I. D., Root R. K., Wolff S. M. Bactericidal and metabolic properties of human eosinophils. Blood. 1972 Jan;39(1):67–80. [PubMed] [Google Scholar]
  11. Olofsson T., Olsson I., Venge P., Elgefors B. Serum myeloperoxidase and lactoferrin in neutropenia. Scand J Haematol. 1977 Jan;18(1):73–80. doi: 10.1111/j.1600-0609.1977.tb01480.x. [DOI] [PubMed] [Google Scholar]
  12. Olsson I., Venge P., Spitznagel J. K., Lehrer R. I. Arginine-rich cationic proteins of human eosinophil granules: comparison of the constituents of eosinophilic and neutrophilic leukocytes. Lab Invest. 1977 May;36(5):493–500. [PubMed] [Google Scholar]
  13. Panush R. S., Franco A. E., Schur P. H. Rheumatoid arthritis associated with eosinophilia. Ann Intern Med. 1971 Aug;75(2):199–205. doi: 10.7326/0003-4819-75-2-199. [DOI] [PubMed] [Google Scholar]
  14. Spitznagel J. K., Dalldorf F. G., Leffell M. S., Folds J. D., Welsh I. R., Cooney M. H., Martin L. E. Character of azurophil and specific granules purified from human polymorphonuclear leukocytes. Lab Invest. 1974 Jun;30(6):774–785. [PubMed] [Google Scholar]
  15. Steele R. H., Wilhelm D. L. The inflammatory reaction in chemical injury. 3. Leucocytosis and other histological changes induced by superficial injury. Br J Exp Pathol. 1970 Jun;51(3):265–279. [PMC free article] [PubMed] [Google Scholar]
  16. Venge P., Roxin L. E., Olsson I. Radioimmunoassay of human eosinophil cationic protein. Br J Haematol. 1977 Nov;37(3):331–335. doi: 10.1111/j.1365-2141.1977.tb01003.x. [DOI] [PubMed] [Google Scholar]
  17. WROBLEWSKI F., LADUE J. S. Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med. 1955 Oct;90(1):210–213. doi: 10.3181/00379727-90-21985. [DOI] [PubMed] [Google Scholar]
  18. Weissmann G. Activation of neutrophils and the lesions of rheumatoid arthritis. J Lab Clin Med. 1982 Sep;100(3):322–333. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES